Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma
View ORCID ProfileKarolin Heinze, Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu, Samuel C.Y. Leung, Eun Young Kang, Nicola S. Meagher, Catherine J. Kennedy, Jessica Boros, Friedrich Kommoss, Hans-Walter Vollert, Florian Heitze, Andreas du Bois, Philipp Harter, Marcel Grube, Bernhard Kraemer, Annette Staebler, Felix K.F. Kommoss, Sabine Heublein, Hans-Peter Sinn, Naveena Singh, Angela Laslavic, Esther Elishaev, Alex Olawaiye, Kirsten Moysich, Francesmary Modugno, Raghwa Sharma, Alison H. Brand, Paul R. Harnett, Anna DeFazio, Renée T. Fortner, Jan Lubinski, Marcin Lener, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Helena Gronwald, Jacek Gronwald, Penny Coulson, Mona A El-Bahrawy, Michael E. Jones, Minouk J. Schoemaker, Anthony J. Swerdlow, Kylie L. Gorringe, Ian Campbell, Linda Cook, Simon A. Gayther, Michael E. Carney, Yurii B. Shvetsov, Brenda Y. Hernandez, Lynne R. Wilkens, Marc T. Goodman, Constantina Mateoiu, Anna Linder, Karin Sundfeldt, Linda E. Kelemen, Aleksandra Gentry-Maharaj, Martin Widschwendter, Usha Menon, Kelly L. Bolton, Jennifer Alsop, Mitul Shah, Mercedes Jimenez-Linan, Paul D.P. Pharoah, James D. Brenton, Kara L. Cushing-Haugen, Holly R. Harris, Jennifer A. Doherty, Blake Gilks, Prafull Ghatage, David G. Huntsman, Gregg S. Nelson, Anna V. Tinker, Cheng-Han Lee, Ellen L. Goode, Brad H. Nelson, Susan J. Ramus, Stefan Kommoss, Aline Talhouk, Martin Köbel, View ORCID ProfileMichael S. Anglesio
doi: https://doi.org/10.1101/2021.09.16.21262993
Karolin Heinze
1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Tayyebeh M. Nazeran
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Sandra Lee
3University of Calgary, Department of Pathology and Laboratory Medicine, Calgary, AB, Canada
Pauline Krämer
1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
4University Hospital Tübingen, Department of Women’s Health, Tübingen, Germany
Evan S. Cairns
1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
Derek S. Chiu
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Samuel C.Y. Leung
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Eun Young Kang
3University of Calgary, Department of Pathology and Laboratory Medicine, Calgary, AB, Canada
Nicola S. Meagher
5University of New South Wales, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, New South Wales, Australia
6University of New South Wales, School of Women’s and Children’s Health, Sydney, New South Wales, Australia
Catherine J. Kennedy
7The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
8Westmead Hospital, Department of Gynaecological Oncology, Sydney, New South Wales, Australia
Jessica Boros
7The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
8Westmead Hospital, Department of Gynaecological Oncology, Sydney, New South Wales, Australia
Friedrich Kommoss
9Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany
Hans-Walter Vollert
10Medizin Campus Bodensee, Department of Gynecology and Obstetrics, Friedrichshafen, Germany
Florian Heitze
11Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany
Andreas du Bois
11Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany
Philipp Harter
11Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany
Marcel Grube
1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
4University Hospital Tübingen, Department of Women’s Health, Tübingen, Germany
Bernhard Kraemer
4University Hospital Tübingen, Department of Women’s Health, Tübingen, Germany
Annette Staebler
12University Hospital Tübingen, Institute of Pathology and Neuropathology, Tübingen, Germany
Felix K.F. Kommoss
13University Hospital Heidelberg, Institute of Pathology, Heidelberg, Germany
Sabine Heublein
14University Hospital Heidelberg and National Center for Tumor Diseases, Department of Obstetrics and Gynecology, Heidelberg, Germany
Hans-Peter Sinn
13University Hospital Heidelberg, Institute of Pathology, Heidelberg, Germany
Naveena Singh
15Barts Health National Health Service Trust, Department of Pathology, London, UK
Angela Laslavic
16University of Pittsburgh School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, PA, USA
Esther Elishaev
17University of Pittsburgh School of Medicine, Department of Pathology, PA, USA
Alex Olawaiye
16University of Pittsburgh School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, PA, USA
Kirsten Moysich
18Roswell Park Cancer Institute, Department of Cancer Prevention and Control, Buffalo, NY, USA
Francesmary Modugno
16University of Pittsburgh School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, PA, USA
Raghwa Sharma
19Westmead Hospital, Tissue Pathology and Diagnostic Oncology, Sydney, New South Wales, Australia
20University of Sydney, Sydney, New South Wales, Australia
21Western Sydney University, Sydney, New South Wales, Australia
Alison H. Brand
8Westmead Hospital, Department of Gynaecological Oncology, Sydney, New South Wales, Australia
20University of Sydney, Sydney, New South Wales, Australia
Paul R. Harnett
8Westmead Hospital, Department of Gynaecological Oncology, Sydney, New South Wales, Australia
22Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia
Anna DeFazio
7The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
8Westmead Hospital, Department of Gynaecological Oncology, Sydney, New South Wales, Australia
20University of Sydney, Sydney, New South Wales, Australia
23The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia
Renée T. Fortner
24German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany
Jan Lubinski
25Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Centre, Szczecin, Poland
Marcin Lener
25Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Centre, Szczecin, Poland
Aleksandra Tołoczko-Grabarek
25Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Centre, Szczecin, Poland
Cezary Cybulski
25Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Centre, Szczecin, Poland
Helena Gronwald
26Pomeranian Medical University, Department of Propaedeutics, Physical Diagnostics and Dental Physiotherapy, Szczecin, Poland
Jacek Gronwald
25Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Centre, Szczecin, Poland
Penny Coulson
27The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK
Mona A El-Bahrawy
28Imperial College London, Department of Metabolism, Digestion and Reproduction, Hammersmith Hospital, London, UK
Michael E. Jones
27The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK
Minouk J. Schoemaker
27The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK
Anthony J. Swerdlow
27The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK
29The Institute of Cancer Research, Division of Breast Cancer Research, London, UK
Kylie L. Gorringe
30The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, Australia
31Peter MacCallum Cancer Centre, Women’s Cancer Program, Melbourne, Australia
Ian Campbell
30The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, Australia
32Peter MacCallum Cancer Centre, Cancer Genetics Laboratory, Research Division, Melbourne, Australia
Linda Cook
33The University of New Mexico, Division of Epidemiology and Biostatistics, Albuquerque, NM, USA
Simon A. Gayther
34Cedars-Sinai Medical Center, Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Los Angeles, CA, USA
Michael E. Carney
35John A. Burns School of Medicine, University of Hawaii, Honolulu, Department of Obstetrics and Gynecology, HI, USA
Yurii B. Shvetsov
36University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA
Brenda Y. Hernandez
36University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA
Lynne R. Wilkens
36University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA
Marc T. Goodman
37Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, CA, USA
Constantina Mateoiu
38Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Department of Obstetrics and Gynecology, Gothenburg, Sweden
Anna Linder
38Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Department of Obstetrics and Gynecology, Gothenburg, Sweden
Karin Sundfeldt
38Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Department of Obstetrics and Gynecology, Gothenburg, Sweden
Linda E. Kelemen
39Medical University of South Carolina, Hollings Cancer Center and Department of Public Health Sciences, Charleston, SC, USA
Aleksandra Gentry-Maharaj
40University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK
41University College London, Department of Women’s Cancer, Institute for Women’s Health, London, UK
Martin Widschwendter
42University of Innsbruck, EUTOPS Institute, Innsbruck, Austria
Usha Menon
40University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK
Kelly L. Bolton
43Washington University School of Medicine, Department of Hematology and Oncology, Division of Oncology, St. Louis, MO, USA
Jennifer Alsop
44University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK
Mitul Shah
45Addenbrookes Hospital, Department of Histopathology, Cambridge, UK
Mercedes Jimenez-Linan
45Addenbrookes Hospital, Department of Histopathology, Cambridge, UK
Paul D.P. Pharoah
44University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK
46University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK
James D. Brenton
47University of Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK
Kara L. Cushing-Haugen
48Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, WA, USA
Holly R. Harris
48Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, WA, USA
Jennifer A. Doherty
49University of Utah, Huntsman Cancer Institute, Department of Population Health Sciences, Salt Lake City, UT, USA
Blake Gilks
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Prafull Ghatage
50University of Calgary, Department of Oncology, Division of Gynecologic Oncology, Calgary, AB, Canada
David G. Huntsman
1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Gregg S. Nelson
50University of Calgary, Department of Oncology, Division of Gynecologic Oncology, Calgary, AB, Canada
Anna V. Tinker
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
51University of British Columbia, Department of Medicine, Vancouver, BC, Canada
Cheng-Han Lee
52University of Alberta, Department of Laboratory Medicine and Pathology, Edmonton, AB, Canada
Ellen L. Goode
53Mayo Clinic, Department of Health Science Research, Division of Epidemiology, Rochester, MN, USA
Brad H. Nelson
54Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada
Susan J. Ramus
5University of New South Wales, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, New South Wales, Australia
6University of New South Wales, School of Women’s and Children’s Health, Sydney, New South Wales, Australia
Stefan Kommoss
4University Hospital Tübingen, Department of Women’s Health, Tübingen, Germany
Aline Talhouk
1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Martin Köbel
3University of Calgary, Department of Pathology and Laboratory Medicine, Calgary, AB, Canada
Michael S. Anglesio
1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
Article usage
Posted September 21, 2021.
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma
Karolin Heinze, Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu, Samuel C.Y. Leung, Eun Young Kang, Nicola S. Meagher, Catherine J. Kennedy, Jessica Boros, Friedrich Kommoss, Hans-Walter Vollert, Florian Heitze, Andreas du Bois, Philipp Harter, Marcel Grube, Bernhard Kraemer, Annette Staebler, Felix K.F. Kommoss, Sabine Heublein, Hans-Peter Sinn, Naveena Singh, Angela Laslavic, Esther Elishaev, Alex Olawaiye, Kirsten Moysich, Francesmary Modugno, Raghwa Sharma, Alison H. Brand, Paul R. Harnett, Anna DeFazio, Renée T. Fortner, Jan Lubinski, Marcin Lener, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Helena Gronwald, Jacek Gronwald, Penny Coulson, Mona A El-Bahrawy, Michael E. Jones, Minouk J. Schoemaker, Anthony J. Swerdlow, Kylie L. Gorringe, Ian Campbell, Linda Cook, Simon A. Gayther, Michael E. Carney, Yurii B. Shvetsov, Brenda Y. Hernandez, Lynne R. Wilkens, Marc T. Goodman, Constantina Mateoiu, Anna Linder, Karin Sundfeldt, Linda E. Kelemen, Aleksandra Gentry-Maharaj, Martin Widschwendter, Usha Menon, Kelly L. Bolton, Jennifer Alsop, Mitul Shah, Mercedes Jimenez-Linan, Paul D.P. Pharoah, James D. Brenton, Kara L. Cushing-Haugen, Holly R. Harris, Jennifer A. Doherty, Blake Gilks, Prafull Ghatage, David G. Huntsman, Gregg S. Nelson, Anna V. Tinker, Cheng-Han Lee, Ellen L. Goode, Brad H. Nelson, Susan J. Ramus, Stefan Kommoss, Aline Talhouk, Martin Köbel, Michael S. Anglesio
medRxiv 2021.09.16.21262993; doi: https://doi.org/10.1101/2021.09.16.21262993
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma
Karolin Heinze, Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu, Samuel C.Y. Leung, Eun Young Kang, Nicola S. Meagher, Catherine J. Kennedy, Jessica Boros, Friedrich Kommoss, Hans-Walter Vollert, Florian Heitze, Andreas du Bois, Philipp Harter, Marcel Grube, Bernhard Kraemer, Annette Staebler, Felix K.F. Kommoss, Sabine Heublein, Hans-Peter Sinn, Naveena Singh, Angela Laslavic, Esther Elishaev, Alex Olawaiye, Kirsten Moysich, Francesmary Modugno, Raghwa Sharma, Alison H. Brand, Paul R. Harnett, Anna DeFazio, Renée T. Fortner, Jan Lubinski, Marcin Lener, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Helena Gronwald, Jacek Gronwald, Penny Coulson, Mona A El-Bahrawy, Michael E. Jones, Minouk J. Schoemaker, Anthony J. Swerdlow, Kylie L. Gorringe, Ian Campbell, Linda Cook, Simon A. Gayther, Michael E. Carney, Yurii B. Shvetsov, Brenda Y. Hernandez, Lynne R. Wilkens, Marc T. Goodman, Constantina Mateoiu, Anna Linder, Karin Sundfeldt, Linda E. Kelemen, Aleksandra Gentry-Maharaj, Martin Widschwendter, Usha Menon, Kelly L. Bolton, Jennifer Alsop, Mitul Shah, Mercedes Jimenez-Linan, Paul D.P. Pharoah, James D. Brenton, Kara L. Cushing-Haugen, Holly R. Harris, Jennifer A. Doherty, Blake Gilks, Prafull Ghatage, David G. Huntsman, Gregg S. Nelson, Anna V. Tinker, Cheng-Han Lee, Ellen L. Goode, Brad H. Nelson, Susan J. Ramus, Stefan Kommoss, Aline Talhouk, Martin Köbel, Michael S. Anglesio
medRxiv 2021.09.16.21262993; doi: https://doi.org/10.1101/2021.09.16.21262993
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)